ECRD 2020 – all sessions available to you for one year! The 10th edition of the European Conference on Rare Diseases & Orphan Products 2020, which took place exclusively online for the first time on 14 & 15 May, was Read More
Why we are attending – Partner interview, Dr. Wolfram Nothaft, Takeda Pharmaceutical Company Limited – ECRD2020 https://youtu.be/gRYPCoPn0aU Ahead of #ECRD2020 which takes place on 14 and 15 May 2020 exclusively online, we hear from Dr. Wolfram Nothaft, Chief Medical Officer, Read More
NEWS: 1300+ Registered for #ECRD2020 – Last Spaces Available With the European Conference on Rare Diseases & Orphan Products (ECRD) only a few days away, we are delighted to confirm that over 1300 attendees have now completed the online registration Read More
NEWS: Why you should attend ECRD2020 – According to some of our speakers! The European Conference on Rare Diseases & Orphan Products (ECRD) is an unrivalled opportunity to network and exchange invaluable knowledge with all stakeholders in the rare disease community Read More
Why we are attending – Partner interview, Pfizer Rare Disease – ECRD2020 Ahead of #ECRD2020 which takes place on 14 and 15 May 2020 exclusively online, we had a chat with Reda Guiha (RG), Regional President, International Developed Markets, Pfizer Read More
Registration Deadline is 23:59 CET 10 May – ECRD2020 We are happy to announce that the registration deadline for the largest, patient-led rare disease event has now been extended to 10 May 2020. With #ECRD2020 now taking place completely online, Read More
Full Programme Now Available – ECRD2020 #ECRD2020 is happy to announce that the full programme to the largest, patient-led rare disease event is now available on the Conference website. Over two days, the European Conference on Rare Diseases & Orphan Products Read More
NEWS: Industry attendance at ECRD2020 – Who should register? The European Conference on Rare Diseases & Orphan Products (ECRD) is an opportunity for industry to come together with patients to discuss the state-of-the-art in rare disease policy, research, diagnosis, treatment Read More